CIDRAP newsletters options
Same child, same exam—different findings based on who is listening.
This week Pennsylvania added 89 new cases, and Ohio's outbreak grew by 73 infections.
An analysis of 1.4 million medical records finds vaccination tied to a lower risk of head and neck tumors.
Vaccination rates differed significantly by education level and age, and reasons for remaining unvaccinated differed by race and education level.
Alfalfa sprouts sold under the Calco and Everything Sprouts brands are linked to the most recent outbreak of foodborne illness affecting the US.
After a surge in 2022, the virus is now spreading continuously among US residents.
Opposition to President Trump’s recent executive order downplaying childhood vaccines continues to mount.
The vaccine will be used in a phase 3 trial.
Emergency department boarding can be risky for patients. A new paper examines how long people wait to be admitted to the hospital.
The outbreaks are largely preventable through inexpensive, effective vaccination.
A new study finds that the vaccine was 78% effective for any RSV-associated lower respiratory tract disease through age 6 months.
Scientists say younger age and lower rates of chronic conditions are probably not the driving factors.
Though “brain-eating amoeba” infections are rare, they are almost always fatal.
The contaminated peppers were grown in Mexico and distributed by Coast Citrus Distributors.
Experts say people who want the vaccines will be able to access them, and insurance will cover them.
Findings from a 30-plus-year study challenge long-held assumptions about the factors that drive this tickborne disease.
Three shots are not better than one. They involve more injections, more visits, higher costs, more time spent incompletely protected. And no demonstrated benefit.
Historical records describe a disease pattern that challenges longstanding narratives about plague epidemiology in Western Europe.
Respiratory syncytial viruses are linked to nasal colonization with Streptococcus pneumonia, but their specific role is still unclear.
Trump named Heidi Overton, a physician and policy aide, the next commissioner of the Food and Drug Administration.
